BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15674479)

  • 1. Molecular mechanisms of glioma cell migration and invasion.
    Demuth T; Berens ME
    J Neurooncol; 2004 Nov; 70(2):217-28. PubMed ID: 15674479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of migration: invasion of malignant gliomas and implications for treatment.
    Giese A; Bjerkvig R; Berens ME; Westphal M
    J Clin Oncol; 2003 Apr; 21(8):1624-36. PubMed ID: 12697889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor cell invasion, anatomical and biological considerations.
    Thorsen F; Tysnes BB
    Anticancer Res; 1997; 17(6B):4121-6. PubMed ID: 9428345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
    Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
    Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells.
    Ziu M; Schmidt NO; Cargioli TG; Aboody KS; Black PM; Carroll RS
    J Neurooncol; 2006 Sep; 79(2):125-33. PubMed ID: 16598423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targets of glioma invasion.
    Nakada M; Nakada S; Demuth T; Tran NL; Hoelzinger DB; Berens ME
    Cell Mol Life Sci; 2007 Feb; 64(4):458-78. PubMed ID: 17260089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant glioma: neuropathology and neurobiology.
    Preusser M; Haberler C; Hainfellner JA
    Wien Med Wochenschr; 2006 Jun; 156(11-12):332-7. PubMed ID: 16944363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
    Höring E; Harter PN; Seznec J; Schittenhelm J; Bühring HJ; Bhattacharyya S; von Hattingen E; Zachskorn C; Mittelbronn M; Naumann U
    Acta Neuropathol; 2012 Jul; 124(1):83-97. PubMed ID: 22249620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes.
    Delic S; Lottmann N; Jetschke K; Reifenberger G; Riemenschneider MJ
    Neuropathol Appl Neurobiol; 2012 Apr; 38(2):201-12. PubMed ID: 21722156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neurocentric perspective on glioma invasion.
    Cuddapah VA; Robel S; Watkins S; Sontheimer H
    Nat Rev Neurosci; 2014 Jul; 15(7):455-65. PubMed ID: 24946761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and invasion in glioma.
    Onishi M; Ichikawa T; Kurozumi K; Date I
    Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas.
    Akimoto J; Haraoka J; Aizawa K
    Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):91-9. PubMed ID: 22594978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis and invasion in malignant gliomas.
    Chi A; Norden AD; Wen PY
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern.
    Burger MC; Mildenberger IC; Wagner M; Mittelbronn M; Steinbach JP; Bähr O
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rat glioblastoma model with diffuse leptomeningeal gliomatosis induced by intracarotid injection of C6 glioma cells.
    Wasita B; Kamitani H; Kinoshita Y; Mamun MH; Watanabe T
    Neurol Res; 2009 Jun; 31(5):453-62. PubMed ID: 19309540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of TFPI-2 promotes migration and invasion of glioma cells.
    Gessler F; Voss V; Seifert V; Gerlach R; Kögel D
    Neurosci Lett; 2011 Jun; 497(1):49-54. PubMed ID: 21530612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
    Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
    Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.